Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy

Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our echocardiogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Spethmann, Sebastian, Trefzer, Uwe, Knebel, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2014
Materias:
Published online: February, 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975197/
https://www.ncbi.nlm.nih.gov/pubmed/24707247
http://dx.doi.org/10.1159/000360127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975197/
https://www.ncbi.nlm.nih.gov/pubmed/24707247
http://dx.doi.org/10.1159/000360127

Ejemplares similares